ORLANDO, FL -- January 27, 2008 -- Patients with gastrointestinal stromal tumors (GISTs) receiving imatinib therapy must achieve adequate blood plasma levels of the drug to achieve good clinical outcomes.

• 奥兰多，佛罗里达--1月27日，2008--患有胃肠道间质瘤接受伊马替尼疗法必须达到适当的药物血浆浓度以达到良好的临床结果。